We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
OrganiGram Holdings Inc | TSX:OGI | Toronto | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.64 | 2.58 | 2.75 | 0 | 12:00:47 |
Greg Engel, Organigram’s CEO, called the development plans a significant, strategic investment designed to ensure the company retains its leadership position when recreational marijuana is legalized next year. Engel said the highlights of Organigram’s plans are:
“We are committed to this growth because our number-one priority is our ability to offer customers – both now and in the future – consistent access to a range of high-quality products that meet their needs and tastes,” said Engel. “Our three-level indoor production allows us to maximize our footprint, our yields and produce a consistent high-quality product supply for our customers.”
“This is an incredibly exciting time for our Company, as well as the entire industry,” said Engel. “We’re delivering on our vision to be a major national player in both the medical- and adult-recreational cannabis markets. These moves will add value for our shareholders and will create economic growth and opportunities in New Brunswick.”
For more information on expansion plans, please see the extended release at www.Organigram.ca
About Organigram Holdings Inc.
Organigram Holdings Inc. is a TSX Venture Exchange listed Company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).
Organigram has been ranked in the top-10 Clean Technology & Life Sciences Sector on the TSX Venture Exchange 50.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, crop yields - that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward looking statements, whether as a result of new information, future events or otherwise.
For further information, please contact:
Giselle Doiron Director of Investor and Media Relationsinvestorrelations@organigram.ca (506) 801-8986
Greg Engel Chief Executive Officer gengel@organigram.ca
1 Year OrganiGram Chart |
1 Month OrganiGram Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions